Novozymes, Inc. Prevails In Patent Trial Against Danisco; Novozymes, Inc. Wins Case against Competitor Concerning An Infringement Of One Of Novozymes, Inc. ‘Patents On Enzymes For Bioethanol

FRANKLINTON, N.C.--(BUSINESS WIRE)--Aug. 25, 2006--Danisco announced today that the company has withdrawn the product that infringed Novozymes’ patent (Spezyme(R) Ethyl) from the market. Kristian Merser, general counsel in Novozymes states: “We are very pleased with the decision but we are obviously annoyed by the harm the patent infringement has caused on our market for biofuel enzymes. It’s very satisfactory that the court agreed that our patent is valid and has been infringed - considering the large amount of resources we use on research, development and patenting.”